ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,44%
Dow Jones
44 388,04
-0,40%
DAX
21 394,93
-0,11%
Brent Oil
77,705
0,48%
Bitcoin
105 685,28
1,66%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Spherix Inc (SPEX) Cours

Spherix Inc

Spherix Inc (SPEX)

Ivz Sp Eqw A
1,63
0,00
( 0,00% )
Mis à jour : 01:00:00
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,63
Prix Achat
1,56
Prix Vente
1,58
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
8,712M
Clôture Veille
1,63
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
5 345 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,38
Bénéfice par action (BPA)
-4,28
Chiffre d'affairess
2,04M
Bénéfice net
-22,88M

À propos de Spherix Inc

Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

Secteur
Security Brokers & Dealers
Industrie
Security Brokers & Dealers
Site Web
www.dominariholdings.com
Siège social
Wilmington, Delaware, USA
Fondé
-

SPEX Dernières nouvelles

Plus de nouvelles

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board PR Newswire NEW YORK, Feb. 3, 2021 NEW YORK, Feb. 3, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido...

03 Février 2021
PR Newswire (US)

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy Currently in Human Phase 2 Trials for Treatment of Prostate Cancer PR Newswire NEW YORK, Feb. 1, 2021 NEW YORK, Feb. 1, 2021...

01 Février 2021
PR Newswire (US)

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq SPEX), an innovator in biotechnology for diabetes...

12 Janvier 2010
PR Newswire (US)

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

11 Janvier 2010
PR Newswire (US)

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

19 Novembre 2009
PR Newswire (US)

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

19 Novembre 2009
PR Newswire (US)

Spherix Announces Results of Annual Shareholders Meeting

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

19 Novembre 2009
PR Newswire (US)

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

10 Septembre 2009
PR Newswire (US)

Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

BETHESDA, Md., Sept. 3 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

03 Septembre 2009
PR Newswire (US)

Spherix Announces Positive Phase 2 Study Results

Preliminary Data Demonstrates Reduction of HbA1c Levels With Doses an Order of Magnitude Lower than the Dose Used in the Current Phase 3 Trial. BETHESDA, Md., June 24 /PRNewswire-FirstCall/...

24 Juin 2009
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SPEX - Frequently Asked Questions (FAQ)

What is the current Spherix share price?
The current share price of Spherix is US$ 1,63
How many Spherix shares are in issue?
Spherix has 5 345 000 shares in issue
What is the market cap of Spherix?
The market capitalisation of Spherix is USD 8,71M
What is the 1 year trading range for Spherix share price?
Spherix has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Spherix?
The price to earnings ratio of Spherix is -0,38
What is the cash to sales ratio of Spherix?
The cash to sales ratio of Spherix is 4,27
What is the reporting currency for Spherix?
Spherix reports financial results in USD
What is the latest annual turnover for Spherix?
The latest annual turnover of Spherix is USD 2,04M
What is the latest annual profit for Spherix?
The latest annual profit of Spherix is USD -22,88M
What is the registered address of Spherix?
The registered address for Spherix is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Spherix website address?
The website address for Spherix is www.dominariholdings.com
Which industry sector does Spherix operate in?
Spherix operates in the SECURITY BROKERS & DEALERS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NVNINVNI Group Ltd
US$ 4,96
(232,89%)
339,43M
GOEVCanoo Inc
US$ 0,55
(66,67%)
262,16M
EVAXEvaxion Biotech AS
US$ 6,0399
(65,93%)
52,05M
PCLAPicoCELA Inc
US$ 4,575
(48,54%)
3,6M
NEUPNeuphoria Therapeutics Inc
US$ 5,14
(47,28%)
24,16M
GODNUGolden Star Acquisition Corporation
US$ 3,60
(-72,01%)
13,32k
GODNGolden Star Acquisition Corporation
US$ 2,80
(-67,19%)
289,01k
NXTTNext Technology Holding Inc
US$ 1,461
(-51,94%)
2,16M
SGLYSingularity Future Technology Ltd
US$ 1,6189
(-38,68%)
833,4k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0606
(40,28%)
723,06M
NVNINVNI Group Ltd
US$ 4,95
(232,21%)
339,55M
GOEVCanoo Inc
US$ 0,548599
(66,24%)
262,16M
RIMEAlgorhythm Holdings Inc
US$ 0,0366
(7,33%)
250,9M
RGTIRigetti Computing Inc
US$ 13,365
(-0,78%)
191,59M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SPEX
Spherix
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés